Clinical Trial Update: Efficacy and Safety Study of Elagolix in Women With Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating efficacy and safety of elagolix in women with endometriosis shows completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Elagolix (elagolix)

Snippet

Sponsor: AbbVie | Conditions: Endometriosis, Pain | Phase 2 | Status: COMPLETED | Results posted: 2018-09-26